Wednesday, September 21, 2016

Floxin Otic


Floxin Otic is a brand name of ofloxacin otic, approved by the FDA in the following formulation(s):


FLOXIN OTIC (ofloxacin - solution/drops; otic)



  • Manufacturer: DAIICHI

    Approval date: December 16, 1997

    Strength(s): 0.3% [RLD][AT]

Has a generic version of Floxin Otic been approved?


A generic version of Floxin Otic has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Floxin Otic and have been approved by the FDA:


ofloxacin solution/drops; otic



  • Manufacturer: ALCON PHARMS LTD

    Approval date: March 17, 2008

    Strength(s): 0.3% [AT]


  • Manufacturer: APOTEX INC

    Approval date: September 28, 2007

    Strength(s): 0.3% [AT]


  • Manufacturer: BAUSCH AND LOMB

    Approval date: March 17, 2008

    Strength(s): 0.3% [AT]


  • Manufacturer: FERA PHARMS

    Approval date: August 11, 2009

    Strength(s): 0.3% [AT]


  • Manufacturer: HI TECH PHARMA

    Approval date: March 17, 2008

    Strength(s): 0.3% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Floxin Otic. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Topical preparation for treating otopathy
    Patent 5,401,741
    Issued: March 28, 1995
    Inventor(s): Sato; Kiichi & Handa; Akira & Kitahara; Takeji
    Assignee(s): Daiichi Pharmaceutical Co., Ltd.
    A topical preparation for treating otophathy which contains ofloxacin or a salt thereof as an active ingredient is disclosed.
    Patent expiration dates:

    • March 27, 2012
      ✓ 
      Patent use: METHOD OF TREATING OTOPATHY



See also...

  • Floxin Otic Consumer Information (Drugs.com)
  • Floxin Otic Solution Consumer Information (Wolters Kluwer)
  • Floxin Otic Consumer Information (Cerner Multum)
  • Ofloxacin Solution Consumer Information (Wolters Kluwer)
  • Ofloxacin otic Consumer Information (Cerner Multum)
  • Floxin Otic Advanced Consumer Information (Micromedex)
  • Ofloxacin Otic Advanced Consumer Information (Micromedex)

No comments:

Post a Comment